CClinicalTrials.gg
RecruitingNCT07406100CRUSHUpdated Apr 24, 2026

Piloting the Competence in Romance and Understanding Sexual Health Curriculum

An interventional study of Competence in Romance and Understanding Sexual Health (CRUSH) in Autism, Autism Disorder and Autism Spectrum Disorder, sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether the CRUSH curriculum is possible (feasible), whether it fits the needs of the adults it is designed for (acceptable), and shows initial signs of being helpful (efficacious). CRUSH is a group-based behavioral intervention plus 1-1 coaching designed to provide sexual education and improve the skills of autistic adults for intimate relationships.

The main goals of the project are to:

  • Evaluate the feasibility and acceptability of the CRUSH curriculum in the context of a clinical trial with a waitlist control condition.
  • Initial exploration of how the CRUSH curriculum works and whether it is helpful.

Participants will complete:

  • A screening call.
  • Confirmation of clinical characteristics (autism features, language ability, cognitive ability).
  • 3 visits to assess knowledge and behaviors related to dating and sexual health at each point throughout the training curriculum (before beginning, midway, and after finishing).
  • 20 sessions of the CRUSH curriculum plus 1-1 coaching sessions. After each session, provide feedback about the session.
Read the detailed description

There are currently no evidence-based interventions to improve the dating and sexual health of autistic adults. The CRUSH (Competence in Romance and Understanding Sexual Health) Curriculum was designed to address this critical gap, which was piloted with a small group of participants. This study is a pilot program of the CRUSH curriculum for 40 participants to acquire initial feasibility and acceptability data. It will also test the feasibility and acceptability of the measurement battery for potential inclusion in future clinical trials. The goal of this clinical trial is to learn whether the CRUSH curriculum is possible (feasible), whether it fits the needs of the adults it is designed for (acceptable), how it works (mechanism), and shows initial signs of being helpful (efficacious). CRUSH is a group-based behavioral intervention plus 1-1 coaching designed to provide sexual education and improve the skills of autistic adults for intimate relationships.

The main goals of the project are to:

  • Evaluate the feasibility and acceptability of the CRUSH curriculum in the context of a clinical trial with a waitlist control condition.
  • Initial exploration of how the CRUSH curriculum works and whether it is helpful.

Participants will complete:

  • A screening call.
  • Confirmation of clinical characteristics (autism features, language ability, cognitive ability).
  • 3 visits to assess knowledge and behaviors related to dating and sexual health at each point throughout the training curriculum (before beginning, midway, and after finishing).
  • 20 sessions of the CRUSH curriculum plus 1-1 coaching sessions. After each session, provide feedback about the session.
02

Conditions studied

  • Autism
  • Autism Disorder
  • Autism Spectrum Disorder

Keywords

  • sexual health
  • romantic relationships
03

In context

Autistic Disorder

1,344 studies on the registry are indexed under Autistic Disorder; 334 are open to participants now.

This study's planned enrollment of 40 is below the median of 45 across 1,044 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18;0 to 30;11 years old;
  • Either documentation of a prior diagnosis of autism spectrum disorder or receipt of services based on an autism spectrum diagnosis OR self identification as being autistic / on the autism spectrum and meeting the clinical cut-off on either the Autism Diagnostic Observation Schedule or the Autism Spectrum Quotient;
  • Ability to provide consent for the protocol and understand task demands. The Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-2) may be used to confirm cognitive level. In prior work, adults with full scale IQ of 70 or above on the WASI-2 typically meet this criterion, but a licensed clinician will review individuals who fall below an IQ of 70 on an individual basis to determine eligibility;
  • Fluent in English.

Exclusion criteria

Exclusion Criteria:

  • Non-English-speaking participants (less than 50% of speech in English);
  • Known genetic etiology of ASD (e.g., Fragile X);
  • Major mental illness (e.g., bipolar disorder, schizophrenia, or psychosis);
  • Medical conditions that impact sexual function (e.g., pituitary tumor);
  • Significant sensory, motor, or physical conditions that would prevent valid participation in assessments or intervention;
  • Live more than 50 miles from the site in Brookline, MA where intervention and assessment sessions will be offered.
  • Receipt of other sexual health/dating curricula as an adult.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    CRUSH Intervention

    Participants will receive the CRUSH Curriculum

    Behavioral: Competence in Romance and Understanding Sexual Health (CRUSH)

  • No intervention
    Waitlist

    Will be invited to receive the CRUSH intervention at the end of the study period

Interventions

  • BehavioralCompetence in Romance and Understanding Sexual Health (CRUSH)

    Manualized curriculum targeting sexual health and behavior in intimate relationships designed to meet the specific needs of autistic adults

06

What researchers measure

Primary outcomes

  1. Acceptability Rating Scale

    This is the primary acceptability outcome. Likert ratings with a 5-pt scale

    Time frame: Within one day of each intervention session and at the Baseline, Midpoint (10 weeks), and Post-intervention visit (20 weeks)

  2. Sexual Vocabulary Test - Pragmatics Total Score

    This is the primary measure of target engagement. A measure of the ability to provide definitions of sexual health terms to be used as a measure of target engagement - the primary dependent variable measures pragmatic language (e.g., slang) when discussing sexual health terms. Accuracy (knowledge of sexual health terms) is also collected as a secondary variable.

    Time frame: At the Baseline, Midpoint (10-weeks), and Post-intervention (20-weeks) visits

  3. Psychosexual Knowledge Test

    This is the primary clinical outcome measure and assesses changes in the information participants have. This task was adapted for the first RCT of a sexual health curriculum developed for autistic adolescents to assess changes in information. It includes 35 multiple choice and 2 open-ended items that are scored as correct or incorrect.

    Time frame: At the Baseline, Midpoint (10-weeks), and Post-intervention (20-weeks) visits

Secondary outcomes

  1. Feasibility Assessment

    Attrition rates; Missing data rates for assessment instruments

    Time frame: Within one day of each intervention session and at the Baseline, Midpoint (10 weeks), and Post-intervention visit (20 weeks)

07

Study locations

1 of 1 sites recruiting
  • Boston Children's Hospital, Two Brookline Place
    Brookline, Massachusetts 02445, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07406100
Lead sponsor
Boston Children's Hospital
Responsible party
Susan Faja (Associate Professor, Boston Children's Hospital) — Principal investigator
First posted
Feb 12, 2026
Start date
Apr 1, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Apr 24, 2026

Study contacts

Susan Faja, PhD
Contact
ProjectCRUSH@childrens.harvard.edu
6179194108

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion